Abionyx Pharma (ABNX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 4,551 | 4,640 | 5,252 | 675 | 0 |
| Cost of Goods | 3,707 | 4,022 | 4,616 | 416 | 0 |
| Gross Profit | 844 | 618 | 636 | 259 | 0 |
| Operating Expenses | 5,167 | 3,783 | 4,612 | 6,128 | 2,880 |
| Operating Income | -4,323 | -3,165 | -3,976 | -5,869 | -2,880 |
| Interest Expense | 37 | 19 | 61 | 8 | 0 |
| Other Income | -21 | -334 | -169 | 55 | 994 |
| Pre-tax Income | -4,381 | -3,518 | -4,206 | -5,822 | -1,886 |
| Net Income Continuous | -4,381 | -3,518 | -4,206 | -5,822 | -1,886 |
| Net Income | $-4,381 | $-3,518 | $-4,206 | $-5,822 | $-1,886 |
| EPS Basic Total Ops | -0.13 | -0.12 | -0.15 | -0.23 | -0.08 |
| EPS Basic Continuous Ops | -0.13 | -0.12 | -0.15 | -0.23 | -0.08 |
| EPS Diluted Total Ops | -0.13 | -0.12 | -0.15 | -0.23 | -0.08 |
| EPS Diluted Continuous Ops | -0.13 | -0.12 | -0.15 | -0.23 | -0.08 |
| EBITDA(a) | $-4,209 | $-3,346 | $-4,010 | $-5,695 | $-1,864 |